Loading
Adipokines, Inflammation, and Metabolic Diseases / Peroxisome Proliferator-activated Receptors · Journal article
International Journal of Molecular Sciences · August 6, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an in vitro mechanistic study demonstrating that grape seed extract (GE) and garlic extract (ALL) independently inhibit lipid accumulation in 3T3-L1 preadipocytes through distinct pathways, with GE showing greater potency (68% inhibition) than ALL (81.6% of control). The findings are exploratory and establish no clinical utility; they raise hypotheses about the role of proanthocyanidins and thiosulfinates in adipogenesis but require validation in animal models and human studies before informing clinical practice.
In vitro cell culture study. 3T3-L1 mouse preadipocyte cell line during differentiation. Intervention: Grape seed extract (Vitis vinifera, rich in oligomeric proanthocyanidins) and/or garlic extract (Allium sativum bulb, rich in thiosulfinates) at non-cytotoxic concentrations (approximately 23 μg/mL allicin and 0.05% OPCs at 1:600 dilution). Compared with: Control untreated differentiating preadipocytes.
Grape seed extract (GE) reduced lipid accumulation to 68.0% of control, the most potent inhibition among all treatments Garlic extract (ALL) reduced lipid accumulation to 81.6% of control Combined extract (AGE) reduced lipid accumulation to 78.0% of control, showing no synergistic enhancement
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
These findings are not clinically actionable at present. They suggest potential mechanisms by which plant extracts might modulate adipogenesis but provide no evidence of efficacy in humans or even intact animal models. Further preclinical work and clinical trials would be required before recommending these extracts for obesity management.
In vitro mechanistic study in a preadipocyte cell line with no animal or human validation; demonstrates differential effects on lipid accumulation and gene expression but lacks clinical relevance and independent replication.
As stated by the source record.
Quoted from the source exactly as published.
These findings are not clinically actionable at present. They suggest potential mechanisms by which plant extracts might modulate adipogenesis but provide no evidence of efficacy in humans or even intact animal models. Further preclinical work and clinical trials would be required before recommending these extracts for obesity management.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Obesity and its associated metabolic disorders drive the search for natural compounds with anti-adipogenic properties. This study evaluated Vitis vinifera seed extract (GE), rich in oligomeric proanthocyanidins (OPCs), and Allium sativum bulb extract (ALL), rich in thiosulfinates, for their effects on adipogenesis and COX-related prostanoid modulation in 3T3-L1 cells. Differentiating preadipocytes were treated with non-cytotoxic concentrations of GE, ALL, or their combination (AGE) at a 1:600 dilution (approximately 23 μg/mL allicin and 0.05% OPCs). Lipid accumulation was assessed by Oil Red O staining, prostanoid levels (PGE2, TXA2, and PGI2) were quantified by enzyme immunoassay, and adipogenic gene expression (PPARγ, CEBPα and GLUT4) was analyzed by RT-qPCR. All treatments reduced lipid accumulation, with GE showing the most potent inhibition (68.0% of control), followed by ALL (81.6%) and AGE (78.0%). Distinct prostanoid patterns emerged: GE increased both PGE2 and PGI2 and decreased TXA2, while ALL increased PGE2 and reduced both TXA2 and PGI2. The combination (AGE) did not enhance the anti-adipogenic effects. At the molecular level, GE downregulated PPARγ, CEBPα, and GLUT4, whereas ALL did not affect their transcription, indicating distinct mechanisms. These findings demonstrate that GE and ALL inhibit adipogenesis through differential modulation of the COX pathway and gene expression, highlighting their potential as functional ingredients for obesity management. The lack of synergy in the combination warrants further investigation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.